FDA Investigator Stephen T Hansen

Stephen T Hansen has conducted inspections on 112 sites in 15 countries as of 15 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
112
Last Inspection Date:
15 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
100006793
Countries of Inspections:
United States of America, Brazil, Germany, Mexico, Japan, France, Spain, Thailand, Austria, Russian Federation, Belgium, Netherlands, Israel, Poland, China
FDA Investigators that have inspected at least one site in common with Stephen T Hansen:
Alan P Kurtzberg, Andrea J Schmidt, Andrea S Heise, Andrew M Kolenc, Barbara J White, Betty Kay Baxter, Blake R Jensen, Bodenw, Brent W Higgs, Carla R Hinz, Carlos Chavez, Christin L Torres, Christina A Mayer, Christine I Shaw, Christopher M Jenner, Corey K Reno, Courtney R Bratina, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Daniel Pst Laurent, Dawn C Olenjack, Deborah S Hammond, Dipti Kalra, Dongping Dai, PhD, Dr. Abhijit Raha, PhD, Dustin M James, Dustin P Tran, Dylan R Jock, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Elvin R Smith, Emily B Camire, Erica R Havely, Erik W Burrows, Erika V Butler, Ethan P Stegman, Farwa Z Razvi, Gary C Pecic, Jr, George A Prager, Ginger M Sykes, Haley H Seymour, Hanna L Potter, Holly L Miller, Holly Sebastian, Hugh M Mcclure, II, Isabel Y Espinosa, James R Montero, Jamie L Dion, Jamie L Port, Janet B Abt, Janet Pulver, Jennifer A Baker, Jennifer A Robinson, Jennifer L Wolfe, Jessie E Morris, Joan M Cantellops Figueroa, Jonathan R Campos, Joo Jin, Joshua A Querl, Joy P Matthias, Juan A Morales, Justin H Erickson, Kamara Co, Karen M Montgomery (KMM), Kathryn A Krentz, Kelly D Moore, Kent C Faul, Kimberley A Hoefen, Kip J Hanks, Kristen E Szenderski, Lance Mde Souza, MBA, Laura B Kennedy, Lauren E Swantko, Linda F Murphy, Linda M Cheny, Manuel A Moreno, Marc A Jackson, Jr, Margaret M Annes, Marion W Nadeau, Martina E Lagrange, Mary F Bodick, Mary T Carden, Matthew A Johnson, Matthew J Hansen, Matthew R Dionne, Maurine Fadlalla, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael R Goga, Michael W Shafer, Michelle J Hines, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Patricia A Maestas, Paul J Teitell, Randy V Bong, Rebecca S Secrist, Ricki A Chase, Roberto A Dookhan, Ruth A Williams, Sandra S Saniga, Santos E Camara, Secrist, Shelley H Beausoleil, Shererk, Sherri J Jackson, Srinivas R Chennamaneni, PhD, Stefanie R Cook, Stephanie A Slater, MS, Sunitha K Rajaram, PhD, Susan L Young, Teena H Aiken, Thaddeus M Steinke, Thai T Duong, Theressa B Smith, Trinidad D Barreras, Uduak M Inokon, Vanessa E Coulter, Vickie J Kanion, Vicky L Cruz, William A Lanier, William F Lagud, Jr, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Miller

Stephen T Hansen's Documents

Publish Date Document Type Title
November, 2014 FDA 483 Matthew J. Cornish, M.D. - Form 483, 2014-11-26
April, 2018 FDA 483 Selzman, Craig, M.D. - Form 483, 2018-04-10
March, 2017 FDA 483 Lynn R. Webster, MD - Form 483, 2017-03-24
June, 2019 FDA 483 Fan Z. Caprio, M.D. - Form 483, 2019-06-14
July, 2017 FDA 483 Pyxant Labs - Form 483, 2017-07-20
November, 2020 EIR Mark A Turner MD - EIR, 2020-11-13
September, 2018 FDA 483 Response HEATHER R. HARRISON, D.O. - Form 483R, 2018-10-05
March, 2016 EIR Richardson, Stephen F. MD - EIR, 2016-03-14
May, 2018 FDA 483 John Meadors - Form 483, 2018-05-07
August, 2014 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2015-01-22
March, 2016 FDA 483 Richardson, Stephen F. MD - Form 483, 2016-03-14
February, 2018 FDA 483 George Rodgers - Form 483, 2018-03-26
May, 2018 FDA 483 CAO Group, Inc. - Form 483, 2018-05-07
December, 2015 FDA 483 Michael W. Harris, D.O. - Form 483, 2015-12-15
March, 2017 EIR Lynn R. Webster, MD - EIR, 2017-03-24
October, 2016 FDA 483 Gabrielsen, Alvin A., Jr., M.D. - Form 483, 2016-10-24
February, 2020 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2020-02-28
June, 2019 EIR Fan Z. Caprio, M.D. - EIR, 2019-06-14
February, 2016 FDA 483 Response Holly L. Spraker, M.D. - Form 483R, 2016-02-26
April, 2020 EIR Leonard J. Swinyer, MD - EIR, 2020-04-17
June, 2017 EIR Yaish, Hassan Dr. - EIR, 2017-06-30
July, 2014 FDA 483 Derek D. Muse, M.D., Clinical Investigator - Form 483, 2014-07-18
January, 2019 FDA 483 Charles Parker, M.D. - Form 483, 2019-01-18
December, 2015 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2016-01-21
September, 2018 FDA 483 HEATHER R. HARRISON, D.O. - Form 483, 2018-10-05
August, 2016 FDA 483 Southwest Bio-Labs, Inc. - Form 483, 2016-08-29
June, 2017 FDA 483 Yaish, Hassan Dr. - Form 483, 2017-06-30
November, 2018 EIR PRA Health Sciences - EIR, 2018-11-02
January, 2014 EIR Nicola Longo, M.D., Ph.D. - EIR, 2014-01-13
September, 2018 FDA 483 Response Ryser, Mark R., D.M.D. - Form 483R, 2018-10-05
May, 2018 EIR CAO Group, Inc. - EIR, 2018-05-07
February, 2020 EIR BioMarin Pharmaceutical Inc. - EIR, 2020-02-28
December, 2015 EIR Michael W. Harris, D.O. - EIR, 2015-12-15
July, 2017 EIR Pyxant Labs - EIR, 2017-07-20
June, 2015 FDA 483 Magdalena Petkova - Form 483, 2015-06-05
September, 2018 FDA 483 Ryser, Mark R., D.M.D. - Form 483, 2018-09-18
September, 2017 EIR University of Utah IRB - EIR, 2017-09-21
October, 2015 EIR Douglass Forsha, MD - EIR, 2015-10-28
August, 2014 EIR Michael W. Harris, D.O. - EIR, 2014-08-29
February, 2016 FDA 483 Holly L. Spraker, M.D. - Form 483, 2016-02-10
October, 2015 FDA 483 Douglass Forsha, MD - Form 483, 2015-10-28
October, 2016 EIR Gabrielsen, Alvin A., Jr., M.D. - EIR, 2016-10-24
May, 2018 FDA 483 Thomas Sutton, MD - Form 483, 2018-05-07
October, 2015 FDA 483 Response Douglass Forsha, MD - Form 483R, 2015-11-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more